Login
Press Releases
Sign up for Email Alerts
Press Release RSS
Find Press Release Containing:
From date:
-Year
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
To date:
-Year
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
Category:
Corporate/Financial News
Philanthropy News
R&D News
Partnering News
08/27/2019
European Commission Approves Empliciti (elotuzumab) Plus Pomalidomide and Low-Dose Dexamethasone (EPd) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Term:
Corporate/Financial News
Language:
English
08/26/2019
Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion
Term:
Corporate/Financial News
Language:
English
08/01/2019
Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo® (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma
Term:
Partnering News
Language:
English
07/29/2019
Bristol-Myers Squibb Announces European Commission Approval of Pending Acquisition of Celgene
Term:
Corporate/Financial News
Language:
English
07/26/2019
Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Empliciti (elotuzumab) Plus Pomalidomide and Low-Dose Dexamethasone for Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Term:
Corporate/Financial News
Language:
English
07/25/2019
Bristol-Myers Squibb Reports Second Quarter Financial Results
Term:
Corporate/Financial News
Language:
English
07/24/2019
Bristol-Myers Squibb Provides Update on Part 2 of CheckMate -227
Term:
R&D News
Language:
English
07/24/2019
Bristol-Myers Squibb Announces CheckMate -227 Part 1a Meets Co-Primary Endpoint of Overall Survival
Term:
R&D News
Language:
English
07/18/2019
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical Enter Into a Clinical Collaboration Agreement to Investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as Combination Therapy in Patients With Metastatic Colorectal Cancer
Term:
Partnering News
Language:
English
07/01/2019
Bristol-Myers Squibb Completes Divestment of UPSA
Term:
Corporate/Financial News
Language:
English
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
Privacy Policy
Business Wire NewsHQ
sm